- Brand names:
- Pharmaceutical Company:
- Condition/Indication: Neuropathic pain
- Meeting Date: May 2022
- Public Summary Document (PSD) May 2022 PBAC Meeting - (PDF 577KB)
- Public Summary Document (PSD) May 2022 PBAC Meeting - (Word 88KB)
Pregabalin – May 2022
Pregabalin: Tablet 82.5 mg, Tablet 165 mg, Tablet 330 mg; Lyrica® CR – May 2022
Last updated
9 September 2022